<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02234336</url>
  </required_header>
  <id_info>
    <org_study_id>14-004757</org_study_id>
    <nct_id>NCT02234336</nct_id>
  </id_info>
  <brief_title>Assessment of Wall Thickness in Hypertrophic Cardiomyopathy</brief_title>
  <official_title>Assessment of Wall Thickness in Hypertrophic Cardiomyopathy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>GE Healthcare</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Assessment of wall thickness in hypertrophic cardiomyopathy (HCM) is of diagnostic and
      prognostic importance given its known association with sudden cardiac death. However, data
      regarding comparison of imaging modalities for this key measurement is lacking. This study
      seeks to compare assessment of maximum wall thickness between clinically indicated
      echocardiography (with and without contrast) and clinically indicated cardiac magnetic
      resonance imaging.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients receiving clinically indicated echocardiograms and cardiac magnetic resonance
      imaging at Mayo Clinic will be eligible.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2014</start_date>
  <completion_date type="Anticipated">June 2017</completion_date>
  <primary_completion_date type="Anticipated">June 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Left Ventricular Wall Thickness</measure>
    <time_frame>approximately 1 week after enrollment</time_frame>
    <description>All subjects will undergo noncontrast echocardiography, contrast echocardiography and cardiac MRI.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">110</enrollment>
  <condition>Hypertrophic Cardiomyopathy</condition>
  <arm_group>
    <arm_group_label>Subjects with HCM</arm_group_label>
    <description>All subjects will undergo noncontrast echocardiography, contrast echocardiography and cardiac MRI.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Noncontrast echocardiography</intervention_name>
    <arm_group_label>Subjects with HCM</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Contrast Echocardiography</intervention_name>
    <arm_group_label>Subjects with HCM</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Cardiac magnetic resonance imaging</intervention_name>
    <arm_group_label>Subjects with HCM</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patients with hypertrophic cardiomyopathy (HCM)
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Clinically and echocardiographically defined hypertrophic cardiomyopathy.

          2. Clinically indicated transthoracic echocardiography as part of the medical evaluation.

          3. No contradiction to administration of ultrasonic echocardiography contrast.

          4. Planned clinically indicated cardiac magnetic resonance imaging as part of medical
             evaluation.

          5. No contraindication to cardiac magnetic resonance imaging (such as cochlear implants,
             central nervous system aneurysm clips and other implanted medical devices).

          6. Age 18 years and older

        Exclusion Criteria:

        1) Insufficient image quality for determination of maximal wall thickness.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Patricia Pellikka, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Cynthia Cassidy</last_name>
    <phone>507-266-7593</phone>
    <email>mccoycassidy.cynthia@mayo.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Patricia Pellikka, MD</last_name>
    <phone>507-284-2129</phone>
    <email>pellikka.patricia@mayo.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Mayo Clinic in Rochester</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pellikka, MD</last_name>
      <email>pellikka.patricia@mayo.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 5, 2014</study_first_submitted>
  <study_first_submitted_qc>September 5, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 9, 2014</study_first_posted>
  <last_update_submitted>May 23, 2017</last_update_submitted>
  <last_update_submitted_qc>May 23, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 24, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Patricia A. Pellikka</investigator_full_name>
    <investigator_title>Professor of Medicine, College of Medicine</investigator_title>
  </responsible_party>
  <keyword>Echocardiography</keyword>
  <keyword>hypertrophic cardiomyopathy</keyword>
  <keyword>cardiomyopathy</keyword>
  <keyword>magnetic resonance imaging</keyword>
  <keyword>contrast</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiomyopathies</mesh_term>
    <mesh_term>Hypertrophy</mesh_term>
    <mesh_term>Cardiomyopathy, Hypertrophic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

